Dec 19 (Reuters) - BioMarin Pharmaceutical (BMRN) said on Friday it would acquire Amicus Therapeutics (FOLD) for about $4.8 billion, expanding its presence in rare metabolic diseases.
The drugmaker will pay $14.50 per share for Amicus, a premium of 33.1% to the stock's last close. Shares of Amicus surged 30%, while BioMarin rose nearly 5% in premarket trading.
The deal strengthens BioMarin's portfolio with Amicus' approved genetic disorder treatments including Galafold, an oral drug for Fabry disease, which is caused by a faulty gene that leads to a buildup of fatty substances in cells.
Amicus also markets a combination therapy Pombiliti and Opfolda for Pompe disease, a genetic condition in which a complex sugar called glycogen builds up in the body's cells.
Amicus also has U.S. rights to DMX-200, a potential treatment of a type of kidney disease known as focal segmental glomerulosclerosis.
BioMarin intends to finance the deal through a combination of cash on hand and about $3.7 billion of non-convertible debt financing.
The company's total cash and investments at the end of September 30 were about $2 billion.
The acquisition, which is expected to close in the second quarter of 2026, will add revenue immediately after the transaction closes, BioMarin said.
The deal is also expected to add to adjusted profit in the first 12 months after close and be substantially accretive beginning in 2027, the company said.
(Reporting by Christy Santhosh and Sriparna Roy in Bengaluru; Editing by Leroy Leo and Maju Samuel)
LATEST POSTS
- 1
Treasure trove found in Egyptian tomb solves ancient mystery - 2Israel, Gulf states report fresh missile and drone attacks
- 3New Cheetos and Doritos will be free of artificial dyes
- 45 Worldwide Road Food varieties You Should Attempt
- 5Doctor's orders: Eat ice cream, and other tips for a long and healthy life
- Arctic sea ice hits lowest winter level as heat records are shattered worldwide
- Quantum Computing’s Next Major Breakthroughs Could Come From Australia
- First Houthi launch toward Israel since war began triggers alerts across the Negev
- Kiefer Sutherland arrested after allegedly assaulting a ride-share driver in L.A.
- James Webb Space Telescope spies mysterious high-energy radiation in star nursery
- How to see the Ursids, the final meteor shower of 2025
- I thought I knew the night sky, but what I saw from the Canary Islands left me speechless
- Dear Santa: I want Botox. Why cosmetic procedures are topping holiday wish lists.
- Find the Native Culinary Customs: Local Flavors
